Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

PROMOTION
Take 15% off!
Human High Sensitivity IL-6 ELISA Assay
for serum, plasma, and cell culture

Featured Products & Promotions

Latest News
  • soluble NEUROPILIN-1 in sepsis correlates with organ dysfunction
    soluble NEUROPILIN-1 in sepsis correlates with organ dysfunction
    5 November, 2024
    Sepsis is a life-threatening medical condition that arises when the body’s response to an infection triggers widespread inflammation, leading to tissue damage and organ dysfunction. Early recognition and prompt treatment are crucial as sepsis can result in multi-organ failure and death (1). Timely administration of antibiotics and supportive care significantly improve outcomes, highlighting the importance [...]
  • Bone biomarkers in early renal impairment
    Bone biomarkers in early renal impairment
    29 October, 2024
    Kidney dysfunction causes disruptions in bone and mineral metabolism and changes in the regulators of the renal-bone axis through various mechanisms. Studies have demonstrated that fibroblast growth factor 23 (FGF23) and inflammatory markers rise, while iron status may decline (1, 2). In healthy individuals, FGF23 is regulated by phosphate, Vitamin D (1,25(OH)2D), and parathyroid hormone [...]
  • Novel Biomarkers in Breast Cancer
    Novel Biomarkers in Breast Cancer
    22 October, 2024
    Breast cancer is the most prevalent cancer among women globally. Enhancing our knowledge of how breast cancer develops, progresses, and metastasizes could aid in decreasing the risk and impact of the disease. Circulating proteins in serum or plasma can serve as biomarkers of cancer progression and prognosis while also serving as potential therapeutic targets. Enhancing [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events